These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6976465)
1. [Lymphocyte cytotoxicity against HBsAG-coated hepatocytes in patients with chronic hepatitis. I. Significance of T-cell medicated cytotoxicity (author's transl)]. Nonomura A; Nishimura I; Haratake J; Kurumaya H; Oomori K; Kato Y; Kobayashi K; Sugioka G; Ohta G Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1760-71. PubMed ID: 6976465 [No Abstract] [Full Text] [Related]
2. [Lymphocyte cytotoxicity against HBsAg-coated hepatocytes in patients with chronic hepatitis. II. Effects of treatment of target cells with anti-HBs antibody (author's transl)]. Nonomura A; Nishimura I; Kurumaya H; Haratake J; Oomori K; Kato Y; Kobayashi K; Sugioka G; Ohta G Nihon Shokakibyo Gakkai Zasshi; 1981 Oct; 78(10):1947-52. PubMed ID: 6977062 [No Abstract] [Full Text] [Related]
3. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH). Warnatz H; Rösch W; Gerlich W; Gutmann W Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882 [TBL] [Abstract][Full Text] [Related]
4. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection. Alberti A; Realdi G; Bortolotti F; Rigoli AM Gut; 1977 Dec; 18(12):1004-9. PubMed ID: 304824 [TBL] [Abstract][Full Text] [Related]
5. T cell-mediated cytotoxicity against HBsAg-coated Chang cells in patients with chronic hepatitis: evidence for cytotoxicity mediated by delayed hypersensitivity T cell reaction. Nonomura A; Ohmori K; Ohta G; Kato Y; Kobayashi K; Nishimura I; Sugioka G Tohoku J Exp Med; 1982 Oct; 138(2):139-50. PubMed ID: 6983742 [TBL] [Abstract][Full Text] [Related]
6. [Lymphocyte subset cytotoxic to cultured rat hepatocytes in patients with chronic active hepatitis and healthy subjects (author's transl)]. Nonomura A; Haratake J; Karino T; Ohta G Nihon Shokakibyo Gakkai Zasshi; 1980 Feb; 77(2):214-20. PubMed ID: 7401357 [No Abstract] [Full Text] [Related]
7. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease. Mieli-Vergani G; Vergani D; Portmann B; White Y; Murray-Lyon I; Marigold JH; Woolf I; Eddleston AL; Williams R Gut; 1982 Dec; 23(12):1029-36. PubMed ID: 6983473 [TBL] [Abstract][Full Text] [Related]
8. Lymphocyte cytotoxicity for isolated hepatocytes in acute viral and chronic active hepatitis. Cochrane M; Eddleston A; Williams R Minerva Med; 1978 Aug; 69(38):2543-8. PubMed ID: 714256 [No Abstract] [Full Text] [Related]
9. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Naumov NV; Mondelli M; Alexander GJ; Tedder RS; Eddleston AL; Williams R Hepatology; 1984; 4(1):63-8. PubMed ID: 6607203 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149 [TBL] [Abstract][Full Text] [Related]
11. Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH). Barnaba V; Levrero M; Franco A; Ruberti G; Musca A; Bonavita MS; Balsano F Liver; 1986 Feb; 6(1):45-52. PubMed ID: 3487021 [TBL] [Abstract][Full Text] [Related]
12. [Lymphocyte-mediated cytotoxicity against Chang liver cells in acute and chronic active hepatitis (author's transl)]. Hara T Nihon Shokakibyo Gakkai Zasshi; 1977 Dec; 74(12):1679-88. PubMed ID: 609123 [No Abstract] [Full Text] [Related]
13. [Immunologic mechanisms of cell damage and pathogenetic correlations in acute and chronic hepatitis]. Realdi G; Alberti A; Trevisan A; Bortolotti F; Tremolada F; Rigoli AM Minerva Med; 1978 Aug; 69(38):2555-67. PubMed ID: 309565 [No Abstract] [Full Text] [Related]
14. Characterization of the mononuclear cell infiltrate in piecemeal necrosis. Alexander G; Williams R Lab Invest; 1984 Mar; 50(3):247-9. PubMed ID: 6366361 [No Abstract] [Full Text] [Related]
15. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B surface antigen specific cytotoxic T lymphocyte activity in hepatitis B virus infection. Onishi S; Saibara T; Ito K Gastroenterol Jpn; 1985 Aug; 20(4):330-7. PubMed ID: 3876961 [TBL] [Abstract][Full Text] [Related]
17. [Lack of neutrophil activation in children affected with T-lymphocyte deficiencies who are chronic carriers of HBsAg (author's transl)]. De Martino M; Orienti MR; Pisanu C; Biadaioli R; Vierucci A Haematologica; 1979 Aug; 64(4):433-41. PubMed ID: 121578 [No Abstract] [Full Text] [Related]
19. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis. Ortona L; Laghi V; Cauda R; Nervo P Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012 [TBL] [Abstract][Full Text] [Related]
20. Functional implications of hepatitis B surface antigen (HBsAg) in the T cells of chronic HBV carriers. Nagaraju K; Naik SR; Naik S J Viral Hepat; 1997 Jul; 4(4):221-30. PubMed ID: 9278219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]